Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Sundrug (9989.T)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (¥) Price Target (¥) Rating
2022-04-112984-No Rating
2023-10-3040244280Neutral
2023-11-1743024340Neutral
2024-01-0946084520Neutral
2024-05-1640804450Neutral
2024-07-0639324250Neutral
2024-08-1540764190Neutral
2024-11-1437083940Neutral
2025-01-0740904340Neutral
2025-04-1544994880Neutral
2025-05-1645564840Neutral

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.